Kidney Disease

17-30 of 30

• 

  MinuteCE®

  Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes

  Gianluigi Savarese, MD, PhD, FESC, FHFA; James Burton, DM, FRCP

  0.75 credits 3 episodes

  • 

    

    Gianluigi Savarese, MD, PhD, FESC, FHFA

  • 

    

    James Burton, DM, FRCP

  • 

    

    Aaron Wong, MD

  0.75 credits 3 episodes

• 

  RestartResume

  A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care

  RestartResume

  A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care

  MinuteCE®

  A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care

  James Burton, DM, FRCP; Aaron Wong, MD

  0.75 program credits

  • 

    

    James Burton, DM, FRCP

  • 

    

    Aaron Wong, MD

  0.75 program credits

• 

  RestartResume

  Summarizing multidisciplinary strategies: Where do we go from here?

  RestartResume

  Summarizing multidisciplinary strategies: Where do we go from here?

  MinuteCE®

  Summarizing multidisciplinary strategies: Where do we go from here?

  Gianluigi Savarese, MD, PhD, FESC, FHFA

  0.75 program credits

  • 

    

    Gianluigi Savarese, MD, PhD, FESC, FHFA

  0.75 program credits

• 

  RestartResume

  Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy

  RestartResume

  Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy

  MinuteCE®

  Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy

  Gianluigi Savarese, MD

  0.75 program credits

  • 

    

    Gianluigi Savarese, MD

  0.75 program credits

• 

  RestartResume

  Screening for CKM Syndrome

  RestartResume

  Screening for CKM Syndrome

  MinuteCE®

  Screening for CKM Syndrome

  Jürgen Floege, MD

  1.00 program credit

  • 

    

    Jürgen Floege, MD

  1.00 program credit

• 

  RestartResume

  Comprehensive Management of Individuals with CKM Syndrome 

  RestartResume

  Comprehensive Management of Individuals with CKM Syndrome 

  MinuteCE®

  Comprehensive Management of Individuals with CKM Syndrome 

  Muthiah Vaduganathan, MD

  1.00 program credit

  • 

    

    Muthiah Vaduganathan, MD

  1.00 program credit

• 

  RestartResume

  Definition and Staging of CKM Syndrome

  RestartResume

  Definition and Staging of CKM Syndrome

  MinuteCE®

  Definition and Staging of CKM Syndrome

  Carolyn S. P. Lam, MBBS, PhD

  1.00 program credit

  • 

    

    Carolyn S. P. Lam, MBBS, PhD

  1.00 program credit

• 

  RestartResume

  Case-Based Learning and Future Directions

  RestartResume

  Case-Based Learning and Future Directions

  MinuteCE®

  Case-Based Learning and Future Directions

  Carolyn S. P. Lam, MBBS, PhD; Muthiah Vaduganathan, MD, MPH

  1.00 program credit

  • 

    

    Carolyn S. P. Lam, MBBS, PhD

  • 

    

    Muthiah Vaduganathan, MD, MPH

  • 

    

    Jurgen Floege MD

  1.00 program credit

• 

  MinuteCE®

  Optimizing Care for Patients with CKM Syndrome: A Multidisciplinary Approach

  Carolyn S. P. Lam, MBBS, PhD; Jürgen Floege, MD

  1.00 credit 4 episodes

  • 

    

    Carolyn S. P. Lam, MBBS, PhD

  • 

    

    Jürgen Floege, MD

  • 

    

    Muthiah Vaduganathan, MD, MPH

  1.00 credit 4 episodes

• 

  RestartResume

  Nonsteroidal MRAs: The CKD/T1D Potential

  RestartResume

  Nonsteroidal MRAs: The CKD/T1D Potential

  MinuteCE®

  Nonsteroidal MRAs: The CKD/T1D Potential

  John McMurray, MD; Hiddo L. Heerspink, PhD

  1.25 program credits

  • 

    

    John McMurray, MD

  • 

    

    Hiddo L. Heerspink, PhD

  1.25 program credits

• 

  RestartResume

  Nonsteroidal MRAs: The CKD/T2D Advantage

  RestartResume

  Nonsteroidal MRAs: The CKD/T2D Advantage

  MinuteCE®

  Nonsteroidal MRAs: The CKD/T2D Advantage

  John McMurray, MD; Pardeep Jhund, MD, PhD

  1.25 program credits

  • 

    

    John McMurray, MD

  • 

    

    Pardeep Jhund, MD, PhD

  1.25 program credits

• 

  RestartResume

  MOA Deep Dive: The MRA Spectrum

  RestartResume

  MOA Deep Dive: The MRA Spectrum

  MinuteCE®

  MOA Deep Dive: The MRA Spectrum

  John McMurray, MD; Hiddo L. Heerspink, PhD

  1.25 program credits

  • 

    

    John McMurray, MD

  • 

    

    Hiddo L. Heerspink, PhD

  1.25 program credits

• 

  MinuteCE®

  Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care

  Pardeep Jhund, MD, PhD; Hiddo L. Heerspink, PhD

  1.25 credits 10 episodes

  • 

    

    Pardeep Jhund, MD, PhD

  • 

    

    Hiddo L. Heerspink, PhD

  • 

    

    John McMurray, MD

  • 

    

    Akshay S. Desai, MD

  • 

    

    Csaba P. Kovesdy, MD

  • 

    

    Finnian R. McCausland, MD

  • 

    

    Orly Vardeny, MD

  • 

    

    Muthiah Vaduganathan, MD, MPH

  1.25 credits 10 episodes

• 

  RestartResume

  Emerging Evidence in HF Care

  RestartResume

  Emerging Evidence in HF Care

  MinuteCE®

  Emerging Evidence in HF Care

  Pardeep Jhund, MD, PhD; John McMurray, MD

  1.25 program credits

  • 

    

    Pardeep Jhund, MD, PhD

  • 

    

    John McMurray, MD

  1.25 program credits